Concepedia

Franziska Jahn

FJ

Statistics

Publications

8

Citations

320

H-Index

8

Active since

2010

Affiliations

Martin Luther University Halle-Wittenberg(Current)

Heidelberg University

University Hospital Heidelberg

The Medical Oncology Centre of Rosebank

Albert Einstein College of Medicine

Franziska Jahn is an author at Martin Luther University Halle-Wittenberg specializing in pharmacotherapy, medicine, and pharmacology.

ORCID

Top concepts

Publications per year

2010–2023

8

Publications

8

Prevention and management of dermatological toxicities related to anticancer agents: ESMO Clinical Practice Guidelines☆

Mario E. Lacouture, V. Sibaud, Peter Arne Gerber et al. · Annals of Oncology · 2020 · 158 citations · Full text

, , +8

2016 Updated MASCC/ESMO consensus recommendations: Emetic risk classification and evaluation of the emetogenicity of antineoplastic agents

Karin Jordan, Alexandre Chan, Richard J. Gralla et al. · Supportive Care in Cancer · 2016 · 48 citations

, , +10

The NK-1 receptor-antagonist aprepitant in high-dose chemotherapy (highdose melphalan and high-dose T-ICE: paclitaxel, ifosfamide, carboplatin, etoposide): efficacy and safety of a triple antiemetic combination

Karin Jordan, Franziska Jahn, Patrick Jahn et al. · Bone Marrow Transplantation · 2010 · 34 citations

, , +10

Emetic risk classification and evaluation of the emetogenicity of antineoplastic agents—updated MASCC/ESMO consensus recommendation

Karin Jordan, Alexandre Chan, Richard J. Gralla et al. · Supportive Care in Cancer · 2023 · 21 citations · Full text

Safety and Efficacy of Liposomal Cytarabine in the Treatment of Neoplastic Meningitis

Franziska Jahn, Karin Jordan, Timo Behlendorf et al. · Oncology · 2015 · 18 citations

1–5 of 8